PHYSICAL TRAINING IS A UNIVERSAL METHOD OF PULMONARY REHABILITATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE


Cite item

Full Text

Abstract

Aim. To study systemic effects of chronic obstructive pulmonary disease (COPD) of stage III—IV and to assess their response to pulmonary rehabilitation method physical training (PT). Material and methods. The study enrolled 112 patients aged 46-72 years (mean age 64.3 years) with severe and extremely severe COPD. Of them, 57 patients received standard pharmacotherapy, exercise training and training with respiratory trainers. The control group of 55 patients received only pharmacotherapy. At the start and in the end of the study the following parameters were examined: 6-min walk, inspiratory and expiratory muscles performance (Pi, Pe), functional changes in the lungs, quality of life by MOS SF-36 questionnaire, depressive alterations by CES-D questionnaire, markers of systemic inflammation (TNF-alpha, IL-6, IL-1beta, C-reactive protein, testosterone). Results. At the start of the study all the examinees had low exercise tolerance according to 6-min walk test (266,7 м), inspiratory and expiratory muscles performance (Pi 54,8 cm of water, Pe 75,3 cm of water). Patients from the PT group improved the above parameters: pulmonary function, 6-min walk by 80 m, Pi — to 77.2 cm, Pe — to 89.8 cm, functional residual capacity reduced by 14%, residual pulmonary volume by 30%, CRP by 8.1 mg/l, IL-6 by 8.3 pkg/ml, depression regressed, testosterone rose. Patients from the control group improved the above parameters insignificantly. Conclusion. PT is a universal method of pulmonary rehabilitation having a positive action on various COPD systemic effects.

About the authors

N N Mescheryakova

Research Institute of Pulmonology

Email: m_natalia1967@inbox.ru
канд. мед. наук, ст. науч. сотр. лаб. реабилитационных программ и состояния здоровья

A S Belevsky

N.I. Pirogov Medical University

Email: pulmobas@yandex.ru
д-р мед. наук, проф. каф. пульмонологии

A V Chernyak

Research Institute of Pulmonology

Email: achI@2000@mail.ru
канд. мед. наук, зав. лаб. функциональных и ультразвуковых методов исследования

G V Neklyudova

Research Institute of Pulmonology

Email: Nekludova-gala@mail.ru
д-р мед. наук, ст. науч. сотр. лаб. функциональных и ультразвуковых методов исследования

Yu S Lebedin

Research Institute of Pulmonology

канд. мед. наук, вед. науч. сотр. лаб. патологической анатомии и иммунологии

References

  1. Mannino D. M., Buist A. S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370: 765—773.
  2. Celli B. R., MacNee W., Agusti A. G. et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932—946.
  3. Bourdin A., Burgel P., Chanez P. et al. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur. Respir. Rev. 2009; 18: 198—212.
  4. Jolley C. J., Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. J. Eur. Respir. Soc. 2009; 112 (18): 66—80.
  5. Гриппи М.А. Патофизиология легких. М.: Бином; СПб.: Невский диалект; 2008; 21—22.
  6. Agusti A. Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2: 367-0370.
  7. American Thoracic Society / European Respiratory Society Statement on Pulmonary Rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390—1413.
  8. Mills T. L. Comorbid depressive symptomatology: isolating the effects of chronic medical conditions on self-reported depressive symptoms among community-dwelling older adults. Soc. Sci. Med. 2001; 53: 569-578.
  9. Yohannes A.M., Baldwin R.C. Connolly M.J. Prevalence of subthreshold depression in elderly patients with chronic obstructive pulmonary disease. Int. J. Geriatr. Psychiatry 2003; 18: 412—416.
  10. Tze-Pin N., Mathew N., Wan-Cheng T. et al. Depressive Symptoms and Chronic Obstructive Pulmonary Disease. Arch. Intern. Med. 2007; 167 (1): 60—67.
  11. Jordan N., Lee T. A., Marcia V. Effect of depression care on outcomes in COPD patients with depression. CHEST. 2008; 135 (3): 626.
  12. Ng T. P., Niti M., Tan W. C. et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and guality of life. Arch. Intern. Med. 2007; 167: 60—67.
  13. Simon G. E., Von Korff M., Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psycho Med. 2003; 35: 271—279.
  14. Godoy I., Campana A. O., Geraldo R. R. et al. Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients. Eur. Respir. J. 2003; 22: 920—925.
  15. Malo O., Sauleda J., Busguets X. et al. Systemic inflammation during exercerbation of hronic obstructive pulmonary disease. Arch. Bronconeumol. 2002; 38: 172—176.
  16. Debigare R., Marguis K., Cote C. et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124: 83—89.
  17. Sevenoaks M. J., Stockley R. A. Chronic jbstructive pulmonary disease, inflammation and common inflammatory phenotype. Respir. Research. 2006; 7: 70.
  18. Brodsky I. G., Balagopal P., Nair K. S. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. J. Clin. Endocrinol. 1996; 81: 3469—3475.
  19. Ferrando A. A., Tipton K. D., Doyle D. et al. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am. J. Phusiol. 1998; 275: 864—871.
  20. Casaburi R., Goren S., Bhasin S. Substantial prevalence of low anabolic hormone levels in COPD undergoing rehabilitation. Am. J. Respir. Crit. Care Med. 1996; 153: 128.
  21. Pedersen B. K., Toft A. D. Effect of exercise on lymphocytes and cytokines. Br. J. Sports Med. 2000; 34 (4): 246—251.
  22. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111—117.
  23. Lotters F., van Tol B., Kwakkel G., Gosselink R. Effect of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur. Respir. J. 2002; 20: 570—577.
  24. Wanger J., Clausen J. L., Coates A. et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26: 511—522.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies